Prognosis of Localised Prostatic Cancer Managed by “Watch and Wait” Policy
- 1 August 1993
- journal article
- Published by Wiley
- Vol. 72 (2), 214-219
- https://doi.org/10.1111/j.1464-410x.1993.tb00690.x
Abstract
Progression (within 2-7 years) and cancer-specific mortality (within 4-9 years) were examined in 94 patients with localised (T0-T2 NXM0) prostatic cancer. The patients received no initial anti-cancer treatment. A significant difference was found according to the initial T category both in progression (T0 focal 1/13, T0 diffuse 9/53, T1-2 13/28) and in cancer-related death (T0 focal 0/13, T0 diffuse 3/53, T1-2 6/28). Progression (G1 4/48, G2 17/42, G3 2/4) and cancer-related deaths (G1 1/48, G2 7/42, G3 1/4) also showed significant differences according to histological differentiation. No difference could be demonstrated according to age.Keywords
This publication has 20 references indexed in Scilit:
- Prostatic Cancer in Aust-Agder County, Norway: Age, Stage, Grade and Mode of PresentationScandinavian Journal of Urology and Nephrology, 1991
- Radical prostatectomy versus expectant primary treatment in stages I and II prostatic cancer A fifteen-year follow-upUrology, 1990
- The Natural Course of Low Grade, Non-metastatic Prostatic CarcinomaBritish Journal of Urology, 1990
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCERThe Lancet, 1989
- NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONEThe Lancet, 1988
- Pitfalls in preoperative staging in prostate cancerUrology, 1987
- Incidental Carcinoma of the Prostate: Selection for Deferred TreatmentBritish Journal of Urology, 1983
- Understaging and undergrading of prostate cancer Argument for postoperative radiation as adjuvant therapyUrology, 1983
- Prostatic carcinoma influence of tumor grade on results of pelvic lymphadenectomyUrology, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958